Takhzyro
Product Images NDC 47783-644
Product Visual Gallery
This gallery contains 36 technical images submitted to the FDA as part of the official labeling for Takhzyro (NDC 47783-644). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure A (Lanadelumab 01)
Figure B (Lanadelumab 02)
Image (Lanadelumab 03)
Figure C (Lanadelumab 04)
Figure D (Lanadelumab 05)
Figure E (Lanadelumab 06)
Figure F (Lanadelumab 07)
Figure G (Lanadelumab 08)
Figure H (Lanadelumab 09)
Figure I (Lanadelumab 10)
Figure J (Lanadelumab 11)
Figure K (Lanadelumab 12)
Figure L (Lanadelumab 13)
Figure M (Lanadelumab 15)
Figure N (Lanadelumab 14)
Figure O (Lanadelumab 16)
Figure A (Lanadelumab 17)
Figure B (Lanadelumab 18)
Image (Lanadelumab 19)
Figure C (Lanadelumab 20)
Figure D (Lanadelumab 21)
Figure E (Lanadelumab 22)
Figure F (Lanadelumab 23)
Figure G (Lanadelumab 24)
Figure H (Lanadelumab 25)
Figure I (Lanadelumab 26)
Figure J (Lanadelumab 27)
Figure K (Lanadelumab 28)
Figure L (Lanadelumab 29)
Figure M (Lanadelumab 31)
Figure N (Lanadelumab 30)
Figure O (Lanadelumab 32)
Principal Display Panel (2 mL Syringe Carton)
Principal Display Panel (150 mg/mL Syringe Label)
Principal Display Panel (150 mg/mL Syringe Carton)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.